Saptalis Pharmaceuticals LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.saptalis.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 3:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 3
1 (50.0%)Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection
Not Applicable
Not yet recruiting
- Conditions
- Bacterial Infections
- Interventions
- Drug: Likmez® (metronidazole) Oral Suspension
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Saptalis Pharmaceuticals LLC
- Target Recruit Count
- 30
- Registration Number
- NCT07146217
- Locations
- 🇺🇸
Bioresearch Partner, Miami, Florida, United States
🇺🇸Empire Medical Clinical Trials, Miami, Florida, United States
🇺🇸Aavon Clinical Trials, Richmond, Texas, United States
A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies
- First Posted Date
- 2019-06-04
- Last Posted Date
- 2020-10-23
- Lead Sponsor
- Saptalis Pharmaceuticals LLC
- Target Recruit Count
- 126
- Registration Number
- NCT03973775
- Locations
- 🇺🇸
Universal Biopharma Research Institute Inc., Dinuba, California, United States
🇺🇸Long Beach Clinical Trials Services, Inc., Long Beach, California, United States
🇺🇸Havana Research Institute, Pasadena, California, United States
News
No news found